APA (7th ed.) Citation

H, K., R, K., HR, K., H, J., SY, H., JO, P., . . . ST, K. (2022). HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer. Frontiers in oncology, 12, 834104. https://doi.org/10.3389/fonc.2022.834104

Chicago Style (17th ed.) Citation

H, Kim, Kim R, Kim HR, Jo H, Ha SY, Park JO, Park YS, and Kim ST. "HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer." Frontiers in Oncology 12 (2022): 834104. https://doi.org/10.3389/fonc.2022.834104.

MLA (9th ed.) Citation

H, Kim, et al. "HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer." Frontiers in Oncology, vol. 12, 2022, p. 834104, https://doi.org/10.3389/fonc.2022.834104.